Current use of biologicals in thrombosis and haemostasis.
نویسندگان
چکیده
Correspondence to: Prof. Frederick Ofosu, PhD Department of Pathology and Molecular Medicine McMaster University 1200 Main St W, HSC 3N26 Hamilton, Ontario, L8N 3Z5, Canada Tel.: +1 905525914
منابع مشابه
Hormone therapies and venous thromboembolism: where are we now?
Deep vein thrombosis is a common disease, with an incidence of one to three per 1000 individuals per year [1]. Numerous risk factors are known, which can be divided into genetic and acquired [2]. One of the most well-known acquired risk factors is the use of female hormones, i.e. oral contraceptive use or the use of hormone replacement therapy. Apart from the use of hormones orally, other route...
متن کاملA happy new year from Thrombosis and Haemostasis. A 5 year reflection from the editorial team.
For starters, we had some mixed news from the new-style (and perhaps slightly different) Impact Factor from Thomson Reuters, with our 2014 Impact Factor 5.76, and thus a slight drop (sadly) from 2013. However, we see a fall in Impact Factor for most of the thrombosis-focused journals close to us. For example, Thrombosis and Haemostasis’ is now higher than J Thromb Haemost (5.55), ATVB (5.53), T...
متن کاملAsia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery.
The incidence of postoperative venous thromboembolism (VTE) in Asian populations is generally thought to be lower than in Western populations, and the use of thromboprophylaxis after surgery is not routine. This paper is authored by the Asia-Pacific Thrombosis Advisory Board. To provide guidance on the most effective postoperative thromboprophylaxis management, this paper reviews the available ...
متن کاملPharmacotherapy in cardiovascular diseases and vascular interventions.
1172 The current theme issue of Thrombosis and Haemostasis focuses on antiplatelet, anticoagulative and antithrombotic pharmacotherapy in patients with atherothrombotic diseases and especially those undergoing vascular interventions. This topic is of central importance to the majority of patients treated in most clinical disciplines, but especially in the areas of cardiology, neurology and angi...
متن کاملGaps in translation from trials to practice: non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation.
Worldwide there is a tremendous need for affordable anticoagulants that do not require monitoring. The advent of the non-warfarin oral anticoagulant drugs represents a major advance for stroke prevention in atrial fibrillation (AF). The objectives of this review are to 1) identify gaps in our current knowledge regarding use of these single target anticoagulant drugs; 2) outline the potential im...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Thrombosis and haemostasis
دوره 99 5 شماره
صفحات -
تاریخ انتشار 2008